EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Effect of Acetylcholinesterase Inhibitors on Cerebral Perfusion and Cognition: A Systematic Review

Paulien Moyaert, Soetkin Beun, Eric Achten, Patricia Clement

Journal of Alzheimer’s Disease · 13.06.2023 · 93 (4) · 1211-1221

DOI: 10.3233/jad-221125 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 05.05.2023. Verfasst von Paulien Moyaert und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Sciences, Ghent University, Ghent, Belgium. Hauptthemen laut MEDLINE: Dementia, Parkinson Disease, Alzheimer Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Perfusion imaging has the potential to identify neurodegenerative disorders in a preclinical stage. However, to correctly interpret perfusion-derived parameters, the impact of perfusion modifiers should be evaluated.

Objective

In this systematic review, the impact of acute and chronic intake of four acetylcholinesterase inhibitors (AChEIs) on cerebral perfusion in adults was investigated: physostigmine, donepezil, galantamine, and rivastigmine.

Results

Chronic AChEI treatment results in an increase of cerebral perfusion in treatment-responsive patients with Alzheimer’s disease, dementia with Lewy bodies, and Parkinson’s disease dementia in the frontal, parietal, temporal, and occipital lobes, as well as the cingulate gyrus. These effects appear to be temporary, dose-related, and consistent across populations and different AChEI types. On the contrary, further perfusion decline was reported in patients not receiving AChEIs or not responding to the treatment.

Conclusion

AChEIs appear to be a potential perfusion modifier in neurodegenerative patients. More research focused on quantitative perfusion in both patients with and without a cholinergic deficit is needed to draw conclusions on whether AChEI intake should be considered when analyzing perfusion data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DementiaParkinson DiseaseAlzheimer DiseaseHumansCholinesterase InhibitorsAcetylcholinesterasePiperidinesIndansPhenylcarbamatesRivastigmineGalantamineCognitionPerfusionCerebrovascular Circulation

Stichwörter der Autor:innen

Acetylcholinesterase inhibitorsalzheimer’s diseasebiological variationdiagnosisperfusion

Substanzen

Cholinesterase InhibitorsAcetylcholinesterasePiperidinesIndansPhenylcarbamatesRivastigmineGalantamine

Autor:innen und Institutionen

  • Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.
  • Lawson Health Research Institute, London, ON, Canada.
  • Department of Medical Imaging, Ghent University Hospital, Ghent, Belgium.

Zitieren

APA

Moyaert, P., Beun, S., Achten, E., & Clement, P. (2023). Effect of Acetylcholinesterase Inhibitors on Cerebral Perfusion and Cognition: A Systematic Review. Journal of Alzheimer’s Disease, 93(4), 1211-1221. https://doi.org/10.3233/jad-221125

Vancouver

Moyaert P, Beun S, Achten E, Clement P. Effect of Acetylcholinesterase Inhibitors on Cerebral Perfusion and Cognition: A Systematic Review. Journal of Alzheimer’s Disease. 2023;93(4):1211-1221. doi:10.3233/jad-221125

BibTeX
@article{Moyaert2023,
  author = {Moyaert, Paulien and Beun, Soetkin and Achten, Eric and Clement, Patricia},
  title = {Effect of Acetylcholinesterase Inhibitors on Cerebral Perfusion and Cognition: A Systematic Review},
  journal = {Journal of Alzheimer’s Disease},
  year = {2023},
  volume = {93},
  number = {4},
  pages = {1211--1221},
  doi = {10.3233/jad-221125}
}
Kostenlos starten →